Medicare Enrolled

Dr. Jorge Ortega, MD

Pulmonary Disease · Miami, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
198 NW 37TH AVE FL 2, Miami, FL 33125
3052675544
In practice since 2005 (20 years)
NPI: 1508852674 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ortega from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ortega? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ortega

Dr. Jorge Ortega is a pulmonary disease specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ortega performed 1,981 Medicare services across 950 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ortega received a total of $8,369 from 19 pharmaceutical and/or device companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ortega is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 32% volume in FL $8,369 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 53973 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
1,981
Medicare services
Top 32% in FL for pulmonary disease
950
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~99 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
852 $69 $238
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
451 $44 $131
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
112 $106 $354
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
107 $114 $462
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
65 $71 $245
Inpatient or observation ventilation management
Follow-up care for a patient receiving ventilator support during an inpatient stay or observation period. This service involves the ongoing management and adjustment of breathing assistance.
61 $56 $226
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
60 $103 $343
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
48 $151 $671
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
45 $32 $190
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
43 $36 $139
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
43 $47 $179
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
39 $188 $753
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
21 $135 $545
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
17 $95 $355
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
17 $60 $227
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,369
Total received (2018-2024)
Avg $1,196/year across 7 years
Top 24% in FL for pulmonary disease
19
Companies
236
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,239 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$129 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,580
2023
$1,025
2022
$911
2021
$401
2020
$394
2019
$2,004
2018
$2,055

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$3,547
AstraZeneca Pharmaceuticals LP
$1,321
Sunovion Pharmaceuticals Inc.
$1,024
Boehringer Ingelheim Pharmaceuticals, Inc.
$664
Inspire Medical Systems, Inc.
$297
Genentech USA, Inc.
$283
Paratek Pharmaceuticals, Inc.
$219
GENZYME CORPORATION
$194
Mylan Specialty L.P.
$149
Actelion Pharmaceuticals US, Inc.
$140
Insmed, Inc.
$132
Vapotherm Inc
$90
Amgen Inc.
$77
United Therapeutics Corporation
$75
Resmed Corp
$60
Philips North America LLC
$33
Philips Electronics North America Corporation
$33
Hikma Pharmaceuticals USA
$15
Teva Pharmaceuticals USA, Inc.
$14
Top 3 companies account for 70.4% of total payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AirSense · Arikayce · BEVESPI AEROSPHERE · BREZTRI · BROVANA · DUPIXENT · Esbriet · FASENRA · INSPIRE · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Precision Flow · QVAR · Ryaltris · SEEBRI · SPIRIVA · SPIRIVA RESPIMAT · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UPTRAVI · UTIBRON NEOHALER · Utibron · VAPOTHERM · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $422 per 100 Medicare services performed
Looking for a pulmonary disease specialist in Miami?
Compare pulmonary diseases in the Miami area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
128
Per 100K population
4.8
County median income
$68,694
Nearest hospital
MIAMI VA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ortega is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ortega experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Ortega performed 852 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ortega receive payments from pharmaceutical companies?
Yes. Dr. Ortega received a total of $8,369 from 19 companies across 236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ortega's costs compare to other pulmonary diseases in Miami?
Dr. Ortega's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ortega) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →